{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:43:44Z","timestamp":1792457024723,"version":"4.5.0"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM139430"],"award-info":[{"award-number":["R35GM139430"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Specialized pro-resolving mediators (SPMs) promote resolution of inflammation, clear infections and stimulate tissue regeneration. These include resolvins, protectins, and maresins. During self-resolving acute inflammation, SPMs are produced and have key functions activating endogenous resolution response for returning to homeostasis. Herein, we addressed whether infections initiated with ongoing inflammation alter resolution programs, and if low-dose repetitive SPM regimen re-programs the resolution response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Inflammation was initiated with zymosan (1\u00a0mg\/mouse) followed by\n                      <jats:italic>E. coli<\/jats:italic>\n                      (10\n                      <jats:sup>5<\/jats:sup>\n                      \u00a0CFU\/mouse) infections carried out in murine peritonitis, and exudates collected at 4-72\u00a0h. Leukocytes were enumerated using light microscopy, percentages of PMN, monocytes and macrophages were determined using flow cytometry, and resolution indices calculated. Lipid mediators and SPM profiles were established using mass spectrometry-based metabololipidomics. Repetitive dosing with a SPM panel consisting of RvD1, RvD2, RvD5, MaR1 and RvE2 (0.1\u00a0ng\/mouse each,\n                      <jats:italic>i.p<\/jats:italic>\n                      .) was given to mice, followed by zymosan challenge. Leukocyte composition, resolution indices and RNA-sequencing were carried out for the repetitive SPM treatments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      <jats:italic>E. coli<\/jats:italic>\n                      infections initiated acute inflammation-resolution programs with temporal SPM production in the infectious exudates. Zymosan-induced inflammation prior to\n                      <jats:italic>E. coli<\/jats:italic>\n                      peritonitis shifted exudate resolution indices and delayed\n                      <jats:italic>E. coli<\/jats:italic>\n                      clearance. Lipid mediator metabololipidomics demonstrated that\n                      <jats:italic>E. coli<\/jats:italic>\n                      infection with ongoing zymosan-induced inflammation shifted the time course of exudate SPMs, activating a SPM cluster that included RvD1, RvD5 and MaR1 during the initiation phase of infectious inflammation (0-4\u00a0h); RvD5 and MaR1 were present also in the resolution phase (24-48\u00a0h). To emulate daily SPM regimens used in humans, a repetitive subthreshold dosing of the SPM panel RvD1, RvD2, RvD5, MaR1 and RvE2 each at 0.1\u00a0ng per mouse was administered. This low-dose SPM regimen accelerated exudate PMN clearance following zymosan-induced inflammation, and shortened the resolution interval by\u2009&gt;\u200970%. These low-dose SPMs regulated genes and pathways related to immune response, chemokine clearance and tissue repair, as demonstrated by using RNA-sequencing.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Infections encountered during ongoing inflammation in mice reset the resolution mechanisms of inflammation via SPM clusters. Low-dose SPMs activate innate immune responses and pathways towards the resolution response that can be reprogrammed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-024-00877-w","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T10:02:34Z","timestamp":1726653754000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Low-dose pro-resolving mediators temporally reset the resolution response to microbial inflammation"],"prefix":"10.1186","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-8545","authenticated-orcid":false,"given":"Charles N.","family":"Serhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1963-1585","authenticated-orcid":false,"given":"Nan","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-9938","authenticated-orcid":false,"given":"Robert","family":"Nshimiyimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"877_CR1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/cells12010122","volume":"12","author":"S AlZahrani","year":"2022","unstructured":"AlZahrani S, Shinwari Z, Gaafar A, Alaiya A, Al-Kahtani A. Anti-inflammatory effect of specialized proresolving lipid mediators on mesenchymal stem cells: an in vitro study. Cells. 2022;12:122.","journal-title":"Cells"},{"key":"877_CR2","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.3390\/molecules28124728","volume":"28","author":"P Araujo","year":"2023","unstructured":"Araujo P, Iqbal S, Arn\u00f8 A, Espe M, Holen E. Validation of a liquid-liquid extraction method to study the temporal production of D-Series resolvins by head kidney cells from atlantic salmon (Salmon salar) exposed to docosahexaenoic acid. Molecules. 2023;28:4728.","journal-title":"Molecules"},{"key":"877_CR3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/mi.2015.99","volume":"9","author":"H Arnardottir","year":"2016","unstructured":"Arnardottir H, Orr SK, Dalli J, Serhan CN. Human milk proresolving mediators stimulate resolution of acute inflammation. Mucosal Immunol. 2016;9:757\u201366.","journal-title":"Mucosal Immunol"},{"key":"877_CR4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41366-024-01482-x","volume":"48","author":"A Barden","year":"2024","unstructured":"Barden A, Shinde S, Beilin LJ, Phillips M, Adams L, Bollmann S, et al. Adiposity associates with lower plasma resolvin E1 (Rve1): a population study. Int J Obes (lond). 2024;48:725\u201332.","journal-title":"Int J Obes (lond)"},{"key":"877_CR5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115075","volume":"201","author":"M Bardin","year":"2022","unstructured":"Bardin M, Pawelzik SC, Lagrange J, Mahdi A, Arnardottir H, Regnault V, et al. The resolvin D2 - GPR18 axis is expressed in human coronary atherosclerosis and transduces atheroprotection in apolipoprotein E deficient mice. Biochem Pharmacol. 2022;201: 115075.","journal-title":"Biochem Pharmacol"},{"key":"877_CR6","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112808","volume":"42","author":"P Bhattacharya","year":"2023","unstructured":"Bhattacharya P, Dhawan UK, Hussain MT, Singh P, Bhagat KK, Singhal A, et al. Efferocytes release extracellular vesicles to resolve inflammation and tissue injury via prosaposin-GPR37 signaling. Cell Rep. 2023;42: 112808.","journal-title":"Cell Rep"},{"key":"877_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13054-024-04803-8","volume":"28","author":"R Blaauw","year":"2024","unstructured":"Blaauw R, Calder PC, Martindale RG, Berger MM. Combining proteins with n-3 PUFAs (EPA + DHA) and their inflammation pro-resolution mediators for preservation of skeletal muscle mass. Crit Care. 2024;28:38.","journal-title":"Crit Care"},{"key":"877_CR8","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature11042","volume":"484","author":"N Chiang","year":"2012","unstructured":"Chiang N, Fredman G, B\u00e4ckhed F, Oh SF, Vickery TW, Schmidt BA, et al. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature. 2012;484:524\u20138.","journal-title":"Nature"},{"key":"877_CR9","doi-asserted-by":"crossref","first-page":"25372","DOI":"10.1074\/jbc.M002863200","volume":"275","author":"CB Clish","year":"2000","unstructured":"Clish CB, Levy BD, Chiang N, Tai H-H, Serhan CN. Oxidoreductases in lipoxin A4 metabolic inactivation. J Biol Chem. 2000;275:25372\u201380.","journal-title":"J Biol Chem"},{"key":"877_CR10","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1096\/fj.201600375R","volume":"30","author":"A Croasdell","year":"2016","unstructured":"Croasdell A, Sime PJ, Phipps RP. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes. FASEB J. 2016;30:3181\u201393.","journal-title":"FASEB J"},{"key":"877_CR11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00213-017-4774-7","volume":"235","author":"S Deyama","year":"2018","unstructured":"Deyama S, Shimoda K, Suzuki H, Ishikawa Y, Ishimura K, Fukuda H, et al. Resolvin E1\/E2 ameliorate lipopolysaccharide-induced depression-like behaviors via ChemR23. Psychopharmacology. 2018;235:329\u201336.","journal-title":"Psychopharmacology"},{"key":"877_CR12","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1073\/pnas.1100329108","volume":"108","author":"B Diamond","year":"2011","unstructured":"Diamond B, Tracey KJ. Mapping the immunological homunculus. Proc Natl Acad Sci U S A. 2011;108:3461\u20132.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"877_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","volume":"22","author":"M Divangahi","year":"2021","unstructured":"Divangahi M, Aaby P, Khader SA, Barreiro LB, Bekkering S, Chavakis T, et al. Trained immunity, tolerance, priming and differentiation: distinct immunological processes. Nat Immunol. 2021;22:2\u20136.","journal-title":"Nat Immunol"},{"key":"877_CR14","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41467-021-26516-0","volume":"12","author":"J Dort","year":"2021","unstructured":"Dort J, Orfi Z, Fabre P, Molina T, Conte TC, Greffard K, et al. Resolvin-D2 targets myogenic cells and improves muscle regeneration in Duchenne muscular dystrophy. Nat Commun. 2021;12:6264.","journal-title":"Nat Commun"},{"key":"877_CR15","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","volume":"211","author":"J Endo","year":"2014","unstructured":"Endo J, Sano M, Isobe Y, Fukuda K, Kang JX, Arai H, et al. 18-HEPE, an n-3 fatty acid metabolite released by macrophages, prevents pressure overload-induced maladaptive cardiac remodeling. J Exp Med. 2014;211:1673\u201387.","journal-title":"J Exp Med"},{"key":"877_CR16","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202301495R","volume":"37","author":"G Ferri","year":"2023","unstructured":"Ferri G, Serano M, Isopi E, Mucci M, Mattoscio D, Pecce R, et al. Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. FASEB J. 2023;37: e23233.","journal-title":"FASEB J"},{"key":"877_CR17","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1016\/j.ajpath.2023.08.011","volume":"193","author":"H Fitzgerald","year":"2023","unstructured":"Fitzgerald H, Bonin JL, Khan S, Eid M, Sadhu S, Rahtes A, et al. Resolvin D2-G-Protein Coupled Receptor 18 Enhances Bone Marrow Function and Limits Steatosis and Hepatic Collagen Accumulation in Aging. Am J Pathol. 2023;193:1953\u201368.","journal-title":"Am J Pathol"},{"key":"877_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-023-00984-x","author":"G Fredman","year":"2024","unstructured":"Fredman G, Serhan CN. Specialized pro-resolving mediators in vascular inflammation and atherosclerotic cardiovascular disease. Nat Rev Cardiol. 2024. https:\/\/doi.org\/10.1038\/s41569-023-00984-x.","journal-title":"Nat Rev Cardiol"},{"key":"877_CR19","doi-asserted-by":"crossref","first-page":"110097","DOI":"10.1016\/j.isci.2024.110097","volume":"27","author":"S Geng","year":"2024","unstructured":"Geng S, Zhang Y, Lu R, Irimia D, Li L. Resolving neutrophils through genetic deletion of TRAM attenuate atherosclerosis pathogenesis. Iscience. 2024;27:110097.","journal-title":"Iscience"},{"key":"877_CR20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1146\/annurev-pharmtox-051921-085014","volume":"63","author":"JZ Haeggstr\u00f6m","year":"2023","unstructured":"Haeggstr\u00f6m JZ, Newcomer ME. Structures of leukotriene biosynthetic enzymes and development of new therapeutics. Annu Rev Pharmacol Toxicol. 2023;63:407\u201328.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"877_CR21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1515\/cclm-2021-0644","volume":"59","author":"I Hartling","year":"2021","unstructured":"Hartling I, Cremonesi A, Osuna E, Lou PH, Lucchinetti E, Zaugg M, et al. Quantitative profiling of inflammatory and pro-resolving lipid mediators in human adolescents and mouse plasma using UHPLC-MS\/MS. Clin Chem Lab Med. 2021;59:1811\u201323.","journal-title":"Clin Chem Lab Med"},{"key":"877_CR22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704163","volume":"12","author":"H Hasturk","year":"2021","unstructured":"Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, et al. Safety and preliminary efficacy of a novel host-modulatory therapy for reducing gingival inflammation. Front Immunol. 2021;12: 704163.","journal-title":"Front Immunol"},{"key":"877_CR23","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/j.jid.2018.03.1498","volume":"138","author":"J Hellmann","year":"2018","unstructured":"Hellmann J, Sansbury BE, Wong B, Li X, Singh M, Nuutila K, et al. Biosynthesis of D-series resolvins in skin provides insights into their role in tissue repair. J Invest Dermatol. 2018;138:2051\u201360.","journal-title":"J Invest Dermatol"},{"key":"877_CR24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41540-022-00222-z","volume":"8","author":"M Hoch","year":"2022","unstructured":"Hoch M, Smita S, Cesnulevicius K, Lescheid D, Schultz M, Wolkenhauer O, et al. Network- and enrichment-based inference of phenotypes and targets from large-scale disease maps. NPJ Syst Biol Appl. 2022;8:13.","journal-title":"NPJ Syst Biol Appl"},{"key":"877_CR25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.prostaglandins.2005.04.004","volume":"78","author":"S Hong","year":"2005","unstructured":"Hong S, Tjonahen E, Morgan EL, Yu L, Serhan CN, Rowley AF. Rainbow trout (Oncorhynchus mykiss) brain cells biosynthesize novel docosahexaenoic acid-derived resolvins and protectins\u2014mediator lipidomic analysis. Prostaglandins Other Lipid Mediat. 2005;78:107\u201316.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"877_CR26","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jasms.2006.09.002","volume":"18","author":"S Hong","year":"2007","unstructured":"Hong S, Lu Y, Yang R, Gotlinger KH, Petasis NA, Serhan CN. Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: analysis via electrospray\/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. J Am Soc Mass Spectrom. 2007;18:128\u201344.","journal-title":"J Am Soc Mass Spectrom"},{"key":"877_CR27","doi-asserted-by":"crossref","first-page":"105226","DOI":"10.1016\/j.isci.2022.105226","volume":"25","author":"A Hopke","year":"2022","unstructured":"Hopke A, Lin T, Scherer AK, Shay AE, Timmer KD, Wilson-Mifsud B, et al. Transcellular biosynthesis of leukotriene B(4) orchestrates neutrophil swarming to fungi. Iscience. 2022;25:105226.","journal-title":"Iscience"},{"key":"877_CR28","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2147\/JIR.S454284","volume":"17","author":"Z Huang","year":"2024","unstructured":"Huang Z, Cheng Z, Deng X, Yang Y, Sun N, Hou P, et al. Integrated Bioinformatics Exploration and Preliminary Clinical Verification for the Identification of Crucial Biomarkers in Severe Cases of COVID-19. J Inflamm Res. 2024;17:1561\u201376.","journal-title":"J Inflamm Res"},{"key":"877_CR29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s10020-023-00756-w","volume":"29","author":"H Jiang","year":"2023","unstructured":"Jiang H, Song D, Zhou X, Chen F, Yu Q, Ren L, et al. Maresin1 ameliorates MSU crystal-induced inflammation by upregulating Prdx5 expression. Mol Med. 2023;29:158.","journal-title":"Mol Med"},{"key":"877_CR30","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/hep.23894","volume":"52","author":"KR Karlmark","year":"2010","unstructured":"Karlmark KR, Zimmermann HW, Roderburg C, Gassler N, Wasmuth HE, Luedde T, et al. The fractalkine receptor CX\u2083CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes. Hepatology. 2010;52:1769\u201382.","journal-title":"Hepatology"},{"key":"877_CR31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2014.05.043","volume":"86C","author":"CP Klein","year":"2014","unstructured":"Klein CP, Sperotto ND, Maciel IS, Leite CE, Souza AH, Campos MM. Effects of D-series resolvins on behavioral and neurochemical changes in a fibromyalgia-like model in mice. Neuropharmacology. 2014;86C:57\u201366.","journal-title":"Neuropharmacology"},{"key":"877_CR32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/cdd.2017.177","volume":"25","author":"A Korner","year":"2018","unstructured":"Korner A, Schlegel M, Theurer J, Frohnmeyer H, Adolph M, Heijink M, et al. Resolution of inflammation and sepsis survival are improved by dietary Omega-3 fatty acids. Cell Death Differ. 2018;25:421\u201331.","journal-title":"Cell Death Differ"},{"key":"877_CR33","doi-asserted-by":"crossref","first-page":"20623","DOI":"10.1073\/pnas.1911992116","volume":"116","author":"A Korner","year":"2019","unstructured":"Korner A, Zhou E, Muller C, Mohammed Y, Herceg S, Bracher F, et al. Inhibition of Delta24-dehydrocholesterol reductase activates pro-resolving lipid mediator biosynthesis and inflammation resolution. Proc Natl Acad Sci U S A. 2019;116:20623\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"877_CR34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature12175","volume":"498","author":"T Lammermann","year":"2013","unstructured":"Lammermann T, Afonso PV, Angermann BR, Wang JM, Kastenmuller W, Parent CA, et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature. 2013;498:371\u20135.","journal-title":"Nature"},{"key":"877_CR35","doi-asserted-by":"crossref","first-page":"7557","DOI":"10.1038\/s41467-023-43363-3","volume":"14","author":"ES Lau","year":"2023","unstructured":"Lau ES, Roshandelpoor A, Zarbafian S, Wang D, Guseh JS, Allen N, et al. Eicosanoid and eicosanoid-related inflammatory mediators and exercise intolerance in heart failure with preserved ejection fraction. Nat Commun. 2023;14:7557.","journal-title":"Nat Commun"},{"key":"877_CR36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.healun.2022.12.013","volume":"42","author":"V Leroy","year":"2023","unstructured":"Leroy V, Cai J, Tu Z, McQuiston A, Sharma S, Emtiazjoo A, et al. Resolution of post-lung transplant ischemia-reperfusion injury is modulated via Resolvin D1-FPR2 and Maresin 1-LGR6 signaling. J Heart Lung Transplant. 2023;42:562\u201374.","journal-title":"J Heart Lung Transplant"},{"key":"877_CR37","doi-asserted-by":"crossref","first-page":"23254","DOI":"10.1073\/pnas.1907490116","volume":"116","author":"T Liu","year":"2019","unstructured":"Liu T, Xiang A, Peng T, Doran AC, Tracey KJ, Barnes BJ, et al. HMGB1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis. Proc Natl Acad Sci U S A. 2019;116:23254\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"877_CR38","volume-title":"Cells, tissues, and disease: principles of general pathology","author":"G Majno","year":"2004","unstructured":"Majno G, Joris I. Cells, tissues, and disease: principles of general pathology. New York: Oxford University Press; 2004."},{"key":"877_CR39","doi-asserted-by":"crossref","first-page":"17949","DOI":"10.1073\/pnas.0802572105","volume":"105","author":"SE Malawista","year":"2008","unstructured":"Malawista SE, de Boisfleury CA, van Damme J, Serhan CN. Tonic inhibition of chemotaxis in human plasma. Proc Natl Acad Sci U S A. 2008;105:17949\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"877_CR40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.137713","volume":"5","author":"JF Markworth","year":"2020","unstructured":"Markworth JF, Brown LA, Lim E, Floyd C, Larouche J, Castor-Macias JA, et al. Resolvin D1 supports skeletal myofiber regeneration via actions on myeloid and muscle stem cells. JCI Insight. 2020;5: e137713.","journal-title":"JCI Insight"},{"key":"877_CR41","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1373\/clinchem.2012.190199","volume":"58","author":"E Mas","year":"2012","unstructured":"Mas E, Croft KD, Zahra P, Barden A, Mori TA. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem. 2012;58:1476\u201384.","journal-title":"Clin Chem"},{"key":"877_CR42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1084\/jem.20132103","volume":"211","author":"V Mirakaj","year":"2014","unstructured":"Mirakaj V, Dalli J, Granja T, Rosenberger P, Serhan CN. Vagus nerve controls resolution and pro-resolving mediators of inflammation. J Exp Med. 2014;211:1037\u201348.","journal-title":"J Exp Med"},{"key":"877_CR43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12967-023-04283-4","volume":"21","author":"I M\u00f6ller","year":"2023","unstructured":"M\u00f6ller I, Rodas G, Villal\u00f3n JM, Rodas JA, Angulo F, Mart\u00ednez N, et al. Randomized, double-blind, placebo-controlled study to evaluate the effect of treatment with an SPMs-enriched oil on chronic pain and inflammation, functionality, and quality of life in patients with symptomatic knee osteoarthritis: GAUDI study. J Transl Med. 2023;21:423.","journal-title":"J Transl Med"},{"key":"877_CR44","volume-title":"Metabolic care of the surgical patient","author":"FD Moore","year":"1959","unstructured":"Moore FD. Metabolic care of the surgical patient. Philadelphia and London: W.B. Saunders Company; 1959."},{"key":"877_CR45","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/S0140-6736(12)61684-5","volume":"380","author":"SS Morse","year":"2012","unstructured":"Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. Prediction and prevention of the next pandemic zoonosis. Lancet. 2012;380:1956\u201365.","journal-title":"Lancet"},{"key":"877_CR46","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/acsmedchemlett.9b00596","volume":"11","author":"Y Murakami","year":"2020","unstructured":"Murakami Y, Fukuda H, Muromoto R, Hirashima K, Ishimura K, Fujiwara K, et al. Design and synthesis of benzene congeners of resolvin E2, a proresolving lipid mediator, as its stable equivalents. ACS Med Chem Lett. 2020;11:479\u201384.","journal-title":"ACS Med Chem Lett"},{"key":"877_CR47","doi-asserted-by":"crossref","first-page":"105934","DOI":"10.1016\/j.isci.2023.105934","volume":"26","author":"T Nishina","year":"2023","unstructured":"Nishina T, Deguchi Y, Kawauchi M, Xiyu C, Yamazaki S, Mikami T, et al. Interleukin 11 confers resistance to dextran sulfate sodium-induced colitis in mice. iScience. 2023;26:105934.","journal-title":"iScience"},{"key":"877_CR48","doi-asserted-by":"crossref","first-page":"eaan1471","DOI":"10.1126\/scisignal.aan1471","volume":"10","author":"PC Norris","year":"2017","unstructured":"Norris PC, Libreros S, Chiang N, Serhan CN. A cluster of immunoresolvents links coagulation to innate host defense in human blood. Sci Signal. 2017;10:eaan1471.","journal-title":"Sci Signal"},{"key":"877_CR49","doi-asserted-by":"crossref","first-page":"18050","DOI":"10.1038\/s41598-018-36679-4","volume":"8","author":"PC Norris","year":"2018","unstructured":"Norris PC, Skulas-Ray AC, Riley I, Richter CK, Kris-Etherton PM, Jensen GL, et al. Identification of specialized pro-resolving mediator clusters from healthy adults after intravenous low-dose endotoxin and omega-3 supplementation: a methodological validation. Sci Rep. 2018;8:18050.","journal-title":"Sci Rep"},{"key":"877_CR50","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/biomedicines12010175","volume":"12","author":"CM Padovani","year":"2024","unstructured":"Padovani CM, Yin K. Immunosuppression in sepsis: biomarkers and specialized pro-resolving mediators. Biomedicines. 2024;12:175.","journal-title":"Biomedicines"},{"key":"877_CR51","volume":"16","author":"F Palmas","year":"2021","unstructured":"Palmas F, Clarke J, Colas RA, Gomez EA, Keogh A, Boylan M, et al. Dysregulated plasma lipid mediator profiles in critically ill COVID-19 patients. PLoS ONE. 2021;16: e0256226.","journal-title":"PLoS ONE"},{"key":"877_CR52","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jss.2019.01.038","volume":"238","author":"JL Ramirez","year":"2019","unstructured":"Ramirez JL, Gasper WJ, Khetani SA, Zahner GJ, Hills NK, Mitchell PT, et al. Fish oil increases specialized pro-resolving lipid mediators in PAD (The OMEGA-PAD II Trial). J Surg Res. 2019;238:164\u201374.","journal-title":"J Surg Res"},{"key":"877_CR53","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1096\/fj.13-248393","volume":"28","author":"A Recchiuti","year":"2014","unstructured":"Recchiuti A, Codagnone M, Pierdomenico AM, Rossi C, Mari VC, Cianci E, et al. Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. FASEB J. 2014;28:3090\u2013102.","journal-title":"FASEB J"},{"key":"877_CR54","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nature05877","volume":"447","author":"JM Schwab","year":"2007","unstructured":"Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007;447:869\u201374.","journal-title":"Nature"},{"key":"877_CR55","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.2001025","volume":"206","author":"B Schwarz","year":"2021","unstructured":"Schwarz B, Sharma L, Roberts L, Peng X, Bermejo S, Leighton I, et al. Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators. J Immunol. 2021;206:329\u201334.","journal-title":"J Immunol"},{"key":"877_CR56","doi-asserted-by":"crossref","first-page":"7971","DOI":"10.1073\/pnas.1920193117","volume":"117","author":"M Sekheri","year":"2020","unstructured":"Sekheri M, El Kebir D, Edner N, Filep JG. 15-Epi-LXA(4) and 17-epi-RvD1 restore TLR9-mediated impaired neutrophil phagocytosis and accelerate resolution of lung inflammation. Proc Natl Acad Sci U S A. 2020;117:7971\u201380.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"877_CR57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.25.022106.141647","volume":"25","author":"CN Serhan","year":"2007","unstructured":"Serhan CN. Resolution phases of inflammation: novel endogenous anti-inflammatory and pro-resolving lipid mediators and pathways. Annu Rev Immunol. 2007;25:101\u201337.","journal-title":"Annu Rev Immunol"},{"key":"877_CR58","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510:92\u2013101.","journal-title":"Nature"},{"key":"877_CR59","doi-asserted-by":"crossref","first-page":"5922","DOI":"10.1021\/cr100396c","volume":"111","author":"CN Serhan","year":"2011","unstructured":"Serhan CN, Petasis NA. Resolvins and protectins in inflammation-resolution. Chem Rev. 2011;111:5922\u201343.","journal-title":"Chem Rev"},{"key":"877_CR60","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2023.106718","volume":"166","author":"CN Serhan","year":"2023","unstructured":"Serhan CN, Chiang N. Resolvins and cysteinyl-containing pro-resolving mediators activate resolution of infectious inflammation and tissue regeneration. Prostaglandins Other Lipid Mediat. 2023;166: 106718.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"877_CR61","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100894","volume":"74","author":"CN Serhan","year":"2020","unstructured":"Serhan CN, Gupta SK, Perretti M, Godson C, Brennan E, Li Y, et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med. 2020;74: 100894.","journal-title":"Mol Aspects Med"},{"key":"877_CR62","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101597","volume":"59","author":"CN Serhan","year":"2022","unstructured":"Serhan CN, Libreros S, Nshimiyimana R. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition. Semin Immunol. 2022;59: 101597.","journal-title":"Semin Immunol"},{"key":"877_CR63","volume":"118","author":"AE Shay","year":"2021","unstructured":"Shay AE, Nshimiyimana R, Petasis NA, Haeggstrom JZ, Serhan CN. Human leukocytes selectively convert 4S,5S-epoxy-Resolvin to Resolvin D3, Resolvin D4, and a cys-Resolvin isomer. Proc Natl Acad Sci USA. 2021;118: e2116559118.","journal-title":"Proc Natl Acad Sci USA"},{"key":"877_CR64","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1038\/s41467-022-35604-8","volume":"13","author":"J Shi","year":"2022","unstructured":"Shi J, Wu X, Wang Z, Li F, Meng Y, Moore RM, et al. A genome-wide CRISPR screen identifies WDFY3 as a regulator of macrophage efferocytosis. Nat Commun. 2022;13:7929.","journal-title":"Nat Commun"},{"key":"877_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/iovs.64.14.1","volume":"64","author":"A Singh","year":"2023","unstructured":"Singh A, Cho WJ, Pulimamidi VK, Mittal SK, Chauhan SK. Interleukin-11 suppresses ocular surface inflammation and accelerates wound healing. Invest Ophthalmol vis Sci. 2023;64:1.","journal-title":"Invest Ophthalmol vis Sci"},{"key":"877_CR66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/CIRCRESAHA.119.315506","volume":"126","author":"PR Souza","year":"2020","unstructured":"Souza PR, Marques RM, Gomez EA, Colas RA, De Matteis R, Zak A, et al. Enriched marine oil supplements increase peripheral blood specialized pro-resolving mediators concentrations and reprogram host immune responses: a randomized double-blind placebo-controlled study. Circ Res. 2020;126:75\u201390.","journal-title":"Circ Res"},{"key":"877_CR67","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/nature08541","volume":"461","author":"M Spite","year":"2009","unstructured":"Spite M, Norling LV, Summers L, Yang R, Cooper D, Petasis NA, et al. Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 2009;461:1287\u201391.","journal-title":"Nature"},{"key":"877_CR68","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s00011-024-01885-6","volume":"73","author":"GP Suchitha","year":"2024","unstructured":"Suchitha GP, Devasahayam Arokia Balaya R, Prasad TSK, Dagamajalu S. A signaling network map of Lipoxin (LXA4): an anti-inflammatory molecule. Inflamm Res. 2024;73:1099-1106.","journal-title":"Inflamm Res"},{"key":"877_CR69","doi-asserted-by":"crossref","first-page":"1011944","DOI":"10.3389\/fimmu.2022.1011944","volume":"13","author":"PYK Sundarasivarao","year":"2022","unstructured":"Sundarasivarao PYK, Walker JM, Rodriguez A, Spur BW, Yin K. Resolvin D2 induces anti-microbial mechanisms in a model of infectious peritonitis and secondary lung infection. Front Immunol. 2022;13:1011944.","journal-title":"Front Immunol"},{"key":"877_CR70","doi-asserted-by":"crossref","first-page":"e22639","DOI":"10.1096\/fj.202201407R","volume":"36","author":"HA Taylor","year":"2022","unstructured":"Taylor HA, Finkel T, Gao Y, Ballinger SW, Campo R, Chen R, et al. Scientific opportunities in resilience research for cardiovascular health and wellness. Report from a National Heart, Lung, and Blood Institute workshop. FASEB J. 2022;36:e22639.","journal-title":"FASEB J"},{"key":"877_CR71","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/CIRCULATIONAHA.121.056290","volume":"144","author":"S Verma","year":"2021","unstructured":"Verma S, Bhatt DL, Steg PG, Miller M, Brinton EA, Jacobson TA, et al. Icosapent ethyl reduces ischemic events in patients with a history of previous coronary artery bypass grafting: REDUCE-IT CABG. Circulation. 2021;144:1845\u201355.","journal-title":"Circulation"},{"key":"877_CR72","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1073\/pnas.1820704116","volume":"116","author":"A Wang","year":"2019","unstructured":"Wang A, Pope SD, Weinstein JS, Yu S, Zhang C, Booth CJ, et al. Specific sequences of infectious challenge lead to secondary hemophagocytic lymphohistiocytosis-like disease in mice. Proc Natl Acad Sci U S A. 2019;116:2200\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"877_CR73","doi-asserted-by":"crossref","unstructured":"Wang X, Zhu M, Hjorth E, Cort\u00e9s-Toro V, Eyjolfsdottir H, Graff C, et al. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement. 2015;11:40\u201350.e41\u201342.","DOI":"10.1016\/j.jalz.2013.12.024"},{"key":"877_CR74","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1161\/CIRCULATIONAHA.111.035964","volume":"124","author":"D Westermann","year":"2011","unstructured":"Westermann D, Savvatis K, Lindner D, Zietsch C, Becher PM, Hammer E, et al. Reduced degradation of the chemokine MCP-3 by matrix metalloproteinase-2 exacerbates myocardial inflammation in experimental viral cardiomyopathy. Circulation. 2011;124:2082\u201393.","journal-title":"Circulation"},{"key":"877_CR75","doi-asserted-by":"crossref","unstructured":"Winyard PG, Willoughby DA. Inflammation protocols. In: Methods Mol. Biol. Walker JM (ed.) Humana, Totowa, NJ. 2003.","DOI":"10.1385\/1592593747"},{"key":"877_CR76","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","volume":"37","author":"J Xia","year":"2009","unstructured":"Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37:W652-660.","journal-title":"Nucleic Acids Res"},{"key":"877_CR77","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.clinre.2015.11.009","volume":"40","author":"J Yu","year":"2016","unstructured":"Yu J, Feng Z, Tan L, Pu L, Kong L. Interleukin-11 protects mouse liver from warm ischemia\/reperfusion (WI\/Rp) injury. Clin Res Hepatol Gastroenterol. 2016;40:562\u201370.","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"877_CR78","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/CIRCULATIONAHA.116.021894","volume":"134","author":"MJ Zhang","year":"2016","unstructured":"Zhang MJ, Sansbury BE, Hellmann J, Baker JF, Guo L, Parmer CM, et al. Resolvin D2 enhances postischemic revascularization while resolving inflammation. Circulation. 2016;134:666\u201380.","journal-title":"Circulation"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-00877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-024-00877-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-024-00877-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T18:56:18Z","timestamp":1726772178000},"score":1,"resource":{"primary":{"URL":"https:\/\/molmed.biomedcentral.com\/articles\/10.1186\/s10020-024-00877-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["877"],"URL":"https:\/\/doi.org\/10.1186\/s10020-024-00877-w","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"10 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human peripheral blood mononuclear cells were obtained from the Boston Children's Hospital Blood Bank under the approved Mass General Brigham investigational review board protocol #1999-P-001279. Animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Brigham and Women's Hospital (protocol no. 2016N000145).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declared that there are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"153"}}